Literature DB >> 2529257

Function of a heterologous muscarinic receptor in T cell antigen receptor signal transduction mutants.

M A Goldsmith1, D M Desai, T Schultz, A Weiss.   

Abstract

Previously we have described a system of somatic cell genetics (J.CaM1 and J.CaM2) for analyzing signal transduction via the T cell antigen receptor complex (CD3/Ti). Here we describe a third mutant, J.CaM3, which also expresses high levels of receptors that are functionally impaired. Like J.CaM1, J.CaM3 demonstrates partial signal transduction via CD3/Ti to only certain stimuli. J.CaM1, J.CaM2, and J.CaM3 define three non-Ti complementation groups involved in receptor function. To evaluate the mutations further we have introduced a heterologous receptor, the human muscarinic receptor 1 (HM1), into the parental Jurkat and mutant cell lines. This receptor demonstrates signal transduction competence in all these hosts, indicating that 1) T cells express the necessary apparatus for the coupling of HM1 to second messenger generation and 2) the mutations in the J.CaM family all affect molecules that are specific to CD3/Ti, and not HM1, function. Finally, the HM1 receptor exhibits partial sensitivity to cholera toxin in Jurkat cells, in contrast to the virtually complete sensitivity of CD3/Ti to cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529257

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  The right team at the right time to go for a home run: tyrosine kinase activation by the TCR.

Authors:  Arthur Weiss
Journal:  Nat Immunol       Date:  2010-02       Impact factor: 25.606

3.  Expression of GTP-binding protein alpha subunits in human thymocytes.

Authors:  P S Kabouridis; S T Waters; S Escobar; J Stanners; C D Tsoukas
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

4.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.

Authors:  J E Baker; R Majeti; S G Tangye; A Weiss
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase.

Authors:  E M Genot; C Arrieumerlou; G Ku; B M Burgering; A Weiss; I M Kramer
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Tyrosine phosphorylation of Grb2-associated proteins correlates with phospholipase C gamma 1 activation in T cells.

Authors:  D G Motto; M A Musci; S E Ross; G A Koretzky
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor.

Authors:  J Sudduth-Klinger; M Schumann; P Gardner; D G Payan
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

9.  Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes.

Authors:  S C Chung; T V McDonald; P Gardner
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Measles virus-substance P receptor interaction: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication.

Authors:  G Harrowe; J Sudduth-Klinger; D G Payan
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.